Medicine is shifting from lifelong disease management to one‑time cures. Yet we’re still trying to fund 21st‑century breakthroughs with 20th‑century payment systems. As cell and gene therapies (CGTs) rise, financing built for chronic care is cracking under the pressure.
The blocker is actuarial risk—an insurer’s fear of when a $2 million therapy might appear. This is the Curative Paradox: health value builds over decades, but payment is due overnight. When systems fail to bridge that gap, patients lose.
Precision Financing: A New Model for Cures
Instead of selling one‑off treatments, pharma becomes a long‑term partner.
New models align price with performance:
* Milestone contracts – Refunds if results fall short.
* Annuities – Payments over time, ending if benefits fade.
* Subscriptions – Predictable, population‑based fees (“Netflix for cures”).
* ORBMs – Specialised risk-pooling
* Warranties – Insurance for therapy performance.
Evidence in Action
🇬🇧 England tested annuities that spread therapy costs across years, lowering annual outlay and expanding patient access without breaking budgets.
🇸🇬 Singapore proved speed matters. Through its Company‑Led Submission pilot, it cut CGT reimbursement time by 70% by running value and risk‑sharing talks in parallel with health assessments—accelerating access while maintaining rigor.
The Portability Problem
Even with smart contracts, a cure’s value vanishes when patients switch insurers. New financial architects like Audaire Health (US) and MiCare (Malaysia) track outcomes across payers so refunds and data follow the patient. MiCare even builds subscription‑style coverage that guarantees access to high‑cost therapies.
Who Really Pays?
Healthcare is now a financial architecture with clinical consequences. The tension among payers, providers, and patients is unsustainable. The next leap isn’t scientific—it’s financial.
👉 Precision Financing could be the bridge between miracle cures and sustainable access—redefining insurance not as a monthly bill, but as an investment in human life.
